Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Japanese Encephalitis Vaccines
-
-
The other was an inactivated vaccine cultivated on primary hamster kidney cells (the Beijing-3 strain).Three second-generation vaccines have entered markets since then: SA14-14-2, IC51 and ChimeriVax-JE. The live-attenuated SA14-14-2 strain was introduced in China in 1988.
-
It is much cheaper than alternative vaccines, and is administered to 20 million Chinese children each year. The statistical study is in progress.
Speaker PPTs
- Miao Dong
Isolation and characterization of novel antimicrobial peptides from Japanese medaka plasma
PPT Version | PDF Version - Ganesh Raj Pant
A serological study in response to people at occupational risk of rabies virus exposure in Nepal
PPT Version | PDF Version - Daniela Pencheva
BUL BIO-NCIPD
PPT Version | PDF Version - Wendy peters
A non-replicating Ad5 vaccine for treatment of HSV-2
PPT Version | PDF Version - Randa Hamadeh
Polio returns to Middle East, situation analysis, strategies and way forward
PPT Version | PDF Version - Luiza Guilherme
Streptococcus pyogenes candidate vaccine
PPT Version | PDF Version - Xiao-Song He
Distinct priming effect of live attenuated versus inactivated influenza vaccines in repeated influenza vaccination
PPT Version | PDF Version - Stephanie Ramos
Enhanced Delivery of Dna-Based Vaccines and Immunotherapeutics through Next-Generation Electroporation Devices
PPT Version | PDF Version - Manoj Kumar Chhikara
PDF Version - Charani ranasinghe
Unique IL-4R antagonist and IL-13Ra2 adjuvanted pox viral vector-based HIV vaccines
PPT Version | PDF Version - Sourav Sarkar
MUC1 glycopeptide based anti-cancer vaccines
PPT Version | PDF Version - Robert Lambkin-Williams
Accelerating influenza research; Vaccines, antivirals, immunodulators and monoclonal antibodies. The manufacture of a new H3N2 virus for the human viral challenge model
PPT Version | PDF Version - Didier Betbeder
Nasal administration of antigens using maltodextrin nanoparticles: a mechanistic study
PPT Version | PDF Version - Carmen Alvarez-Dominguez
PDF Version - Zakaria Hmama
A non-genetic approach to improve the tuberculosis vaccine BCG
PPT Version | PDF Version - Filip Dubovsky
PDF Version - Fu Shi Quan
Influenza virus-like particle vaccines elicit protective immunity in the early stage of vaccination
PPT Version | PDF Version - Takahiro Yamada
Status of vaccination against seasonal influenza in pregnant Japanese women: Effect on infection rate among primiparous and multiparous women
PPT Version | PDF Version - De-chu Christopher Tang
Activation of protective innate-adaptive immunity duo for conferring rapid-sustained-broad protection of vaccines against infectious agents
PPT Version | PDF Version - Poonam Salotra
Development of genetically modifi ed live attenuated parasites as potential vaccines against visceral leishmaniasis
PPT Version | PDF Version - Ligia A. Pinto
Immune Responses to Human Papillomavirus Vaccines: What We Have Learned
PPT Version | PDF Version
